Investors
Resonance Health is at an early stage with a clear path to NHS pilots and revenue. We are looking for aligned partners who understand healthcare, digital health, or social impact.
The opportunity
11M
people in the UK with arthritis and MSK conditions
£10.2B
annual NHS cost of MSK conditions
6 months
average wait between specialist visits
Traction & support
- Teesside University FUEL programme & research collaboration
- Platvix Build Studio 2026 cohort
- $100K Azure credits via Microsoft for Startups
- NHS pilot discussions underway
- Working MVP with AI companion (Glow)
Get in touch
We welcome conversations with angels, funds, and strategic partners aligned with UK health innovation.